Neurocircuitry of Addiction: https://www.nature.com/articles/npp2009110#Sec20
Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management: https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13114
Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy: https://www.sciencedirect.com/science/article/abs/pii/S0376871609002890
Perceptions of medications, program settings, and drug use histories among individuals engaged in treatment for opioid use disorder: https://pubmed.ncbi.nlm.nih.gov/36325942/
Moving Addiction Care to the Mainstream — Improving the Quality of Buprenorphine Treatment: https://www.nejm.org/doi/10.1056/NEJMp1804059
Strategies to improve treatment utilization for substance use disorders: A systematic review of intervention studies: https://www.sciencedirect.com/science/article/abs/pii/S0376871620302301
Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2809633
Pharmacologic treatments for opioid dependence: detoxification and maintenance options: https://www.tandfonline.com/doi/full/10.31887/DCNS.2007.9.2/hkleber?src=recsys
Buprenorphine adherence and illicit opioid use among patients in treatment for opioid use disorder: https://www.tandfonline.com/doi/full/10.1080/00952990.2023.2220876?src=recsys
Neurobiologic Advances from the Brain Disease Model of Addiction: https://www.nejm.org/doi/10.1056/NEJMra1511480
Intact responses to non-drug rewards in long-term opioid maintenance treatment: https://www.nature.com/articles/s41386-019-0377-9
